Filing Details
- Accession Number:
- 0001471518-21-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-06 17:43:52
- Reporting Period:
- 2021-08-05
- Accepted Time:
- 2021-08-06 17:43:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1471518 | Louise S. Phanstiel | 320 Wakara Way Salt Lake City UT 84108 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-05 | 30,000 | $25.39 | 109,527 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-05 | 47,881 | $35.04 | 61,646 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-08-05 | 30,000 | $21.29 | 91,646 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-08-05 | 30,000 | $0.00 | 30,000 | $21.29 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-08-05 | 30,000 | $0.00 | 30,000 | $25.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-12-02 | No | 4 | M | Direct | |
| 0 | 2021-12-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 21,000 | Indirect | The Phanstiel Trust |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.49 to $35.50, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The shares subject to this option are fully vested and exercisable.
Billionaire Hedge Funds
